secwatch / observer

Debt Financings

New loans, notes, and credit facilities disclosed under 8-K Items 2.03/2.04.

8-K items 2.03, 2.04 JSON
RLI RLI CORP

RLI CORP amended credit facility of $150 million with PNC Bank, National Association maturing February 26, 2031.

“the Company’s existing credit agreement, dated as of March 30, 2023, to, among other things, extend the maturity date to February 26, 2031, increase the aggregate commitment to $150 million, increase the size of the accordion feature to $50 million and amend the interest rates and certain fees. The foregoing description of the A&R Credit Agreement is qualified in”
RLI RLI CORP

RLI CORP incurred senior notes of $300 million with Computershare Trust Company, National Association at 5.375% maturing due 2036.

“On March 3, 2026, RLI Corp. (the “Company”) completed the public offering of $300 million in aggregate principal amount of its 5.375% Senior Notes due 2036 (the “Notes”).”
RGA REINSURANCE GROUP OF AMERICA INC

REINSURANCE GROUP OF AMERICA INC incurred senior notes of $400 million with The Bank of New York Mellon Trust Company, N.A. at 6.375% per annum maturing September 15, 2056.

“On March 3, 2026, Reinsurance Group of America, Incorporated (the “Company”) completed the offering of $400 million aggregate principal amount of its 6.375% Fixed-Rate Reset Subordinated Debentures due 2056”
LDOS Leidos Holdings, Inc.

Leidos Holdings, Inc. incurred senior notes of $800 million aggregate principal amount of 5.000% senior notes due 2036 with Citibank, N.A. at 5.000% maturing March 15, 2036.

“On March 2, 2026, Leidos, Inc. (the “ Issuer ”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“ Leidos ”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “ 2029 Notes ”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “ 2036 Notes ” and, collectively with the 2029 Notes, the “ Notes ” and, such offering, the “ Notes Offering ”).”
LDOS Leidos Holdings, Inc.

Leidos Holdings, Inc. incurred senior notes of $600 million aggregate principal amount of 4.100% senior notes due 2029 with Citibank, N.A. at 4.100% maturing March 15, 2029.

“On March 2, 2026, Leidos, Inc. (the “ Issuer ”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“ Leidos ”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “ 2029 Notes ”)”
XRN Chiron Real Estate Inc.

Chiron Real Estate Inc. incurred senior notes of up to $150.0 million with NYL Investors LLC and certain affiliates of New York Life maturing no more than ten years from the date of issuance.

“On March 2, 2026, Chiron Real Estate LP (the “Operating Partnership”), as issuer, and Chiron Real Estate Inc., as a guarantor, entered into a Master Note and Guaranty Agreement (the “Agreement”) with NYL Investors LLC (“New York Life”) and certain affiliates of New York Life (collectively, the “Purchasers”). The Agreement establishes an uncommitted senior note facility pursuant to which the Operating Partnership may, from time to time, issue senior unsecured promissory notes (the “Notes”) in one or more series to the Purchasers in an aggregate outstanding principal amount of up to $150.0 million.”
BW Babcock & Wilcox Enterprises, Inc.

Babcock & Wilcox Enterprises, Inc. amended credit facility with Axos Bank maturing January 18, 2028.

“Pursuant to the Tenth Amendment, Axos and the Lenders party to the Credit Agreement agreed to amend certain provisions of the Credit Agreement to, among other things, (i) increase the amounts available to be borrowed based on inventory and receivables in the borrowing base under the Credit Agreement; (ii) extend the maturity date of the Credit Agreement to January 18, 2028; (iii) suspend the PBGC Reserve (provided that the PBGC Reserve shall be re-imposed in the amount of $3,000,000 on January 1, 2027 unless the Company has provided evidence to Axos that the $3,000,000 installment due to the PBGC on or prior to September 15, 2026 has been paid); (iv) modify the covenants relating to deposit account control agreements and institutions to allow for certain holdings in foreign currencies; and (v) release BRC as a specified guarantor thereunder.”
MOG-A MOOG INC.

MOOG INC. amended credit facility with HSBC Bank USA, National Association maturing February 26, 2031.

“The Agreement amended the terms of the Company’s Seventh Amended and Restated Loan Agreement dated as of May 30, 2025. Among other matters, this Agreement extends the maturity of the credit facility from October 27, 2027 to February 26, 2031.”
TRGP Targa Resources Corp.

Targa Resources Corp. incurred senior notes of $750.0 million at 6.050%.

“$750.0 million aggregate principal amount of the Company’s 4.350% Senior Notes due 2031”
RNTX Rein Therapeutics, Inc.

Rein Therapeutics, Inc. incurred senior notes of $2,875,000 with three institutional investors at 20% original issue discount maturing the earlier of (i) the date of the closing of the next issuance and sale of securities of the Company, in a single transaction or series of related transactions.

“On February 24 and 27, 2026, Rein Therapeutics, Inc. (the “Company”) entered into separate securities purchase agreements (each a “Purchase Agreement”) with three institutional investors pursuant to which the Company issued and sold to the investors, in a private placement, unsecured promissory notes in the aggregate original principal amount of $2,875,000 (each a “Note”).”
BAH Booz Allen Hamilton Holding Corp

Booz Allen Hamilton Holding Corp incurred term loan of $750 million with certain lenders maturing February 27, 2031.

“Pursuant to the Eleventh Amendment, certain lenders made terms loans under a new tranche of term loans (the “Tranche A-2 Term Loan”) with a maturity of February 27, 2031 (the fifth anniversary of the Eleventh Amendment Effective Date) under which the Company borrowed an aggregate principal amount of $750 million.”
BAH Booz Allen Hamilton Holding Corp

Booz Allen Hamilton Holding Corp incurred revolving credit of $1.5 billion with Bank of America, N.A., as administrative agent and the lenders from time to time party thereto maturing February 27, 2031.

“Pursuant to the Eleventh Amendment, the Existing Revolving Commitments were replaced in full with new revolving commitments and then increased by $500 million, resulting in aggregate revolving commitments under the Credit Agreement (the “Revolving Credit Facility”) of $1.5 billion, treated as a single revolving tranche, and with a maturity of February 27, 2031.”
MRMD MARIMED INC.

MARIMED INC. incurred senior notes of principal amount of $6,000,000 with Navy Capital Green International, Ltd. and its affiliates at 10.0% per annum maturing March 1, 2031.

“the Company issued to Navy (i) two new promissory notes in the aggregate principal amount of $8,000,000, one in the principal amount of $2,000,000, due March 1, 2028, accruing interest at a rate of 8.0% per annum ("Note #1") and the other in the principal amount of $6,000,000, due March 1, 2031, accruing interest at a rate of 10.0% per annum (subject to reduction to 8% if Note #1 is paid in full within six (6) months of February 24, 2026) ("Note #2" collectively with Note #1, the "New Notes")”
MRMD MARIMED INC.

MARIMED INC. incurred senior notes of aggregate principal amount of $8,000,000 with Navy Capital Green International, Ltd. and its affiliates at 8.0% per annum maturing March 1, 2028.

“the Company issued to Navy (i) two new promissory notes in the aggregate principal amount of $8,000,000, one in the principal amount of $2,000,000, due March 1, 2028, accruing interest at a rate of 8.0% per annum ("Note #1")”
VOYA Voya Financial, Inc.

Voya Financial, Inc. incurred senior notes of $400 million with U.S. Bank Trust Company, National Association at 5.050% per annum maturing March 2, 2036.

“On March 2, 2026, Voya Financial, Inc. (“Voya”) completed its registered public offering (the “Offering”) of $400 million aggregate principal amount of 5.050% Senior Notes due 2036 (the “Notes”).”
HASI HA Sustainable Infrastructure Capital, Inc.

HA Sustainable Infrastructure Capital, Inc. incurred senior notes of $400,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 6.000% maturing 2036.

“issued $400,000,000 aggregate principal amount of its 6.000% Green Senior Unsecured Notes due 2036”
PUBC Purebase Corp

Purebase Corp incurred convertible notes of $1,000,000 with CorTer, LLC at 8% per annum maturing February 27, 2027.

“(“CoreTer”) which is owned and managed by A. Scott Dockter, the Company’s Chief Executive Officer, under which CoreTer agreed to make an unsecured loan to the Company of up to $1,000,000 until February 27, 2027. Any loan amounts may be prepaid by the Company without interest or penalty. On February 27, 2026, the Company also issued an unsecured promissory note to”
TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp. incurred senior notes of $75,000,000 in aggregate principal amount with a qualified institutional investor at 7.50% per year maturing February 27, 2028.

“TriplePoint Venture Growth BDC Corp. (the “Company”) entered into a Master Note Purchase Agreement (the “2026 Master Note Purchase Agreement”) governing the issuance of $75,000,000 in aggregate principal amount of senior unsecured notes due February 27, 2028 with a fixed interest rate of 7.50% per year (the “Series 2026 Notes”) to a qualified institutional investor in a private placement.”
URGN UroGen Pharma Ltd.

UroGen Pharma Ltd. incurred term loan of up to $250,000,000, to be advanced in two tranches; Tranche A Loan of $200,000,000 funded; Tranche B Loan of $50,000,000 with BPCR Limited Partnership, BioPharma Credit Investments V (Master) LP, and BioPharma Credit PLC at 8.25% per annum fixed maturing 5th year anniversary of the Tranche A Closing Date.

“On February 26, 2026, UroGen Pharma Ltd. (the “Company”), and UroGen Pharma, Inc., as the borrower (the “Borrower” and, together with the Company, collectively, the “Credit Parties”), entered into a loan agreement (the “Loan Agreement”) with BPCR Limited Partnership (as a “Lender”), BioPharma Credit Investments V (Master) LP (as a “Lender”), and BioPharma Credit PLC, as collateral agent for the Lenders (in such capacity, the “Collateral Agent”), pursuant to which the Lenders agreed to make term loans to the Borrower in an aggregate principal amount of up to $250,000,000, to be advanced in two tranches (the “Term Loans”).”
WGS GeneDx Holdings Corp.

GeneDx Holdings Corp. incurred term loan of $100.0 million with Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C. (collectively, the “Blackstone Representative”) at Term SOFR adjusted secured overnight financing rate plus a margin of 4.50% maturing five years from the Closing Date.

“The Loan Agreement provides for a term loan in an aggregate principal amount of $100.0 million funded to the Company on the Closing Date (the “Term Loan”).”
CSTAF Constellation Acquisition Corp I

Constellation Acquisition Corp I incurred loan of $5,000 with Constellation Sponsor LP at The Note does not bear interest maturing upon closing of the Company’s initial business combination.

“On February 27, 2026, Constellation Acquisition Corp I (the “Company”) drew an aggregate of $5,000 (the “Extension Funds”), as approved by unanimous director resolution, dated February 26, 2026, pursuant to the unsecured promissory note, dated January 30, 2024 between the Company and Constellation Sponsor LP (the “Note”), which Extension Funds the Company deposited into the Company’s trust account for its public shareholders.”
KKR Private Equity Conglomerate LLC

KKR Private Equity Conglomerate LLC amended revolving credit of increased by $100 million to an aggregate principal amount of $850 million with Sumitomo Mitsui Banking Corporation maturing December 23, 2027.

“the credit available to the Borrowers was increased by $100 million to an aggregate principal amount of $850 million”
OMC OMNICOM GROUP INC.

OMNICOM GROUP INC. incurred senior notes of €600 million aggregate principal amount of 3.850% Senior Notes due 2034 with Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, BNP PARIBAS, HSBC Bank plc, Danske Bank A/S and ING Bank N.V. at 3.850% per year maturing 2034.

“Also on March 2, 2026, Omnicom Finance Holdings plc (the "Euro Notes Issuer"), a wholly owned indirect subsidiary of the Company, closed its public offering of €600 million aggregate principal amount of 3.850% Senior Notes due 2034 (the "Euro Notes," and together with the U.S. Notes, the "Notes"), pursuant to an Underwriting Agreement, dated February 25, 2026 (the "Euro Notes Underwriting Agreement"), with Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, BNP PARIBAS, HSBC Bank plc, Danske Bank A/S and ING Bank N.V.”
OMC OMNICOM GROUP INC.

OMNICOM GROUP INC. incurred senior notes of $400 million aggregate principal amount of 4.200% Senior Notes due 2029, $700 million aggregate principal amount of 5.00 with Citigroup Global Markets Inc., Deutsche Bank Securities Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC at 4.200% per year for 2029 Notes, 5.000% per year for 2033 Notes, 5.300% per year maturing March 2, 2029 for 2029 Notes, June 2, 2033 for 2033 Notes, June 2, 2036 for 2036 Notes.

“On March 2, 2026, Omnicom Group Inc. (the "Company") closed its public offering of $400 million aggregate principal amount of 4.200% Senior Notes due 2029 (the "2029 Notes"), $700 million aggregate principal amount of 5.000% Senior Notes due 2033 (the "2033 Notes") and $600 million aggregate principal amount of 5.300% Senior Notes due 2036 (the "2036 Notes," and together with the 2029 Notes and the 2033 Notes, the "U.S. Notes"), pursuant to the Underwriting Agreement, dated February 25, 2026 (the "U.S. Notes Underwriting Agreement"), with Citigroup Global Markets Inc., Deutsche Bank Securities Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters.”
FMBH FIRST MID BANCSHARES, INC.

FIRST MID BANCSHARES, INC. incurred loan of approximately $20,074,551 with Bankers’ Bank.

“First Mid assumed Two Rivers’ rights, duties and obligations with respect to Two Rivers’ loan with Bankers’ Bank, which had outstanding on February 28, 2026 approximately $20,074,551.”
FMBH FIRST MID BANCSHARES, INC.

FIRST MID BANCSHARES, INC. incurred senior notes of $10,310,000 with The Bank of New York Mellon Trust Company, N.A. maturing March 15, 2035.

“First Mid assumed Two Rivers’ rights, duties and obligations under the Indenture between Two Rivers and the Trustee, dated as of December 30, 2004, pursuant to which Two Rivers has outstanding $10,310,000 of Junior Subordinated Debt Securities due March 15, 2035.”
EACO EACO CORP

EACO CORP incurred guarantee of up to $20,000,000 with Citizens Business Bank.

“By executing the Commercial Guaranty described above, EACO agrees to guarantee up to $20,000,000 of indebtedness under the revolving line of credit and related loan documents.”
EACO EACO CORP

EACO CORP amended credit facility of $20,000,000 with Citizens Business Bank at not less than 4.000% per annum maturing February 15, 2028.

“On February 27, 2026, Bisco Industries, Inc. (“Bisco”), a wholly-owned subsidiary of EACO Corporation (”EACO,” together with Bisco, the “Company”), executed a Change in Terms Agreement dated as of February 15, 2026 (the “Amendment”) with Citizens Business Bank (the “Lender”) in connection with a revolving line of credit (Loan No. 155354101) in the principal amount of $20,000,000.”
PBI PITNEY BOWES INC /DE/

PITNEY BOWES INC /DE/ incurred senior notes of $150,000,000 aggregate principal amount with initial purchasers at 7.250% per annum maturing March 15, 2029.

“On March 2, 2026, Pitney Bowes Inc. (the " Company ") completed an offering (the " Offering ") of $150,000,000 aggregate principal amount of its 7.250% Senior Notes due 2029 (the " Additional Notes ").”
ZYME Zymeworks Inc.

Zymeworks Inc. incurred term loan of $250.0 million with Royalty Pharma Development Funding, LLC at fixed rate maturing December 31, 2042.

“Following the sale and transfer of the Royalty Interest, the Subsidiary entered into a Loan Agreement (the “ Loan Agreement ”), dated March 2, 2026, with Royalty Pharma as administrative agent and lender (in the capacity as lender under the Loan Agreement, the “ Lender ” and together with such other lenders party to the Loan Agreement from time to time the “ Lenders ”), pursuant to which the Lenders made a term loan to the Subsidiary (the “ Loan ”) in an aggregate principal amount of $250.0 million (the “ Loan Amount ”), that bears interest at a fixed rate and matures on December 31, 2042 (the “ Maturity Date ”).”
ARCC ARES CAPITAL CORP

ARES CAPITAL CORP amended credit facility of $1.6 billion with Sumitomo Mitsui Banking Corporation at 1.75% over SOFR or 0.75% over base rate.

“The SMBC Funding Facility Amendment, among other things, (a) increased the commitments under the SMBC Funding Facility from $1.1 billion to $1.6 billion; (b) adjusted the interest rate charged on the SMBC Funding Facility from an applicable spread of either (i) 1.80% over SOFR or (ii) 0.80% over a “base rate” (as defined in the documents governing the SMBC Funding Facility) to an applicable spread of either (x) 1.75% over SOFR or (y) 0.75% over a “base rate” (as defined in the documents governing the SMBC Funding Facility)”
LYRA Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. reported a default on lease obligation with RVAC Medicines (US), Inc..

“On February 23, 2026, Lyra Therapeutics, Inc. (the “Company”) received a notice of default from RVAC Medicines (US), Inc. (“RVAC”) under the sublease agreement dated December 21, 2023 (the “Sublease”) between RVAC, as sublessor, and the Company, as sublessee, for office space located at 880 Winter Street, Suite 1002, Waltham, MA 02451 (the “Premises”).”
TNDM TANDEM DIABETES CARE INC

TANDEM DIABETES CARE INC incurred convertible notes of $300.0 million aggregate principal amount with U.S. Bank Trust Company, National Association at 0.00% maturing March 15, 2032.

“On February 27, 2026, Tandem Diabetes Care, Inc. (the “Company”) completed its previously announced private offering (the “Offering”) of $300.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $35.0 million principal amount of Notes.”
PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd. incurred senior notes of $19.25 million with Wilmington Trust, National Association at three-month SOFR plus 3.20% maturing April 2038.

“(v) $19.25 million of D-R Notes, which bear interest at three-month SOFR plus 3.20%”
PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd. incurred senior notes of $24.5 million with Wilmington Trust, National Association at three-month SOFR plus 2.15% maturing April 2038.

“(iv) $24.5 million of C-R Notes, which bear interest at three-month SOFR plus 2.15%”
PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd. incurred senior notes of $26.25 million with Wilmington Trust, National Association at three-month SOFR plus 1.75% maturing April 2038.

“(iii) $26.25 million of Class B-R Notes, which bear interest at three-month SOFR plus 1.75%”
PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd. incurred senior notes of $14 million with Wilmington Trust, National Association at three-month SOFR plus 1.60% maturing April 2038.

“(ii) $14 million of A-2-R Notes, which bear interest at three-month SOFR plus 1.60%”
PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd. incurred senior notes of $123 million with Wilmington Trust, National Association at three-month SOFR plus 1.43% maturing April 2038.

“(i) $123 million of A-1-R Notes, which bear interest at the three-month secured overnight financing rate (“ SOFR ”) plus 1.43%”
HASI HA Sustainable Infrastructure Capital, Inc.

HA Sustainable Infrastructure Capital, Inc. incurred senior notes of $600,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 7.125% per year maturing 2056.

“On February 27, 2026, HA Sustainable Infrastructure Capital, Inc., a Delaware corporation (the “Company”), issued $600,000,000 aggregate principal amount of its 7.125% Green Junior Subordinated Notes due 2056”
WMS ADVANCED DRAINAGE SYSTEMS, INC.

ADVANCED DRAINAGE SYSTEMS, INC. amended credit facility of $600 million with Bank of America, N.A., PNC Bank, National Association at 162.5 basis points (for Term Benchmark based loans) and 62.5 basis points (for b maturing February 28, 2033.

“refinances the Term Facility under the Existing Credit Agreement by providing a new Term Facility in the initial principal amount of $600 million with a maturity date of February 28, 2033”
WMS ADVANCED DRAINAGE SYSTEMS, INC.

ADVANCED DRAINAGE SYSTEMS, INC. incurred senior notes of $500.0 million aggregate principal amount with U.S. Bank Trust Company, National Association at 5.375% maturing March 1, 2034.

“issued $500.0 million aggregate principal amount of its 5.375% senior notes due 2034”
WH WYNDHAM HOTELS & RESORTS, INC.

WYNDHAM HOTELS & RESORTS, INC. incurred senior notes of $650,000,000 aggregate principal amount with J.P. Morgan Securities LLC and certain other initial purchasers at 5.625% maturing 2033.

“On February 27, 2026, Wyndham Hotels & Resorts, Inc. (the “Company”), the guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), entered into the Seventh Supplemental Indenture (the “Seventh Supplemental Indenture”) to the Indenture, dated April 13, 2018 (the “Base Indenture” and, together with the Seventh Supplemental Indenture, the “Indenture”), in connection with the issuance and sale of $650,000,000 aggregate principal amount of 5.625% senior notes due 2033 (the “Notes”) to J.P. Morgan Securities LLC and certain other initial purchasers (collectively, the “Initial Purchasers”) (the “Offering”).”
BACK IMAC Holdings, Inc.

IMAC Holdings, Inc. incurred loan of $175,000 with a certain lender maturing the date the Holder demands payment in writing.

“On February 26, 2026, IMAC Holdings, Inc. (the “Company”) issued a promissory note (the “Note”) to a certain lender (the “Lender”) in the aggregate principal amount of $175,000 for an aggregate purchase price from the Lenders of $125,000.”
NRGV Energy Vault Holdings, Inc.

Energy Vault Holdings, Inc. incurred convertible notes of $10.0 million additional aggregate principal amount with Jefferies LLC, Cantor Fitzgerald & Co. and Citigroup Global Markets Inc. at 5.250% maturing due 2031.

“On February 25, 2026, the Initial Purchasers notified the Company that they had elected to purchase $10.0 million in additional aggregate principal amount (the "Option Notes," and together with the Initial Notes, the "Notes") of the Company’s 5.250% Convertible Senior Notes due 2031 pursuant to the option granted to them under the Purchase Agreement. On February 27, 2026, the Company issued to the Initial Purchasers the Option Notes on the same terms as the Initial Notes.”
HPS Corporate Lending Fund

HPS Corporate Lending Fund amended credit facility of $2,650,000,000 with Truist Bank, U.S. Bank National Association, Sumitomo Mitsui Banking Corporation, Royal Bank of Canada, BNP Paribas.

“The Commitment Increase Agreement provides for the Assuming Lender's multicurrency commitment and for an increase in each Increasing Lender's commitment, thereby bringing aggregate commitments of the lenders under the Revolving Credit Facility from $2,250,000,000 to $2,650,000,000 through the accordion feature in the Revolving Credit Facility.”
FLD Fold Holdings, Inc.

Fold Holdings, Inc. incurred senior notes of $13.0 million with SATS Credit Fund L.P. at 10.0% per annum maturing one year.

“Contemporaneously with the termination (as described below) of the March 2025 Note (as defined below), Fold Holdings, Inc. (the "Company") entered into a Purchase Agreement with SATS Credit Fund L.P. ("SATS") dated February 25, 2026 (the "Purchase Agreement"), pursuant to which SATS purchased from the Company a $13.0 million promissory note, repayable in cash (the "New Note") and 520,000 shares of the Company's Common Stock (the "Initial Commitment Shares").”
GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. incurred revolving credit of $0.5 billion with JPMorgan Chase Bank, N.A., as administrative agent at alternate base rate, a daily simple SOFR rate, or an adjusted Term SOFR rate for maturing February 25, 2027.

“On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion.”
KSEZ Kinetic Seas Inc.

Kinetic Seas Inc. incurred loan of $148,500 with LABRYS FUND II, L.P. at 8% one-time interest charge maturing February 23, 2027.

“On February 23, 2026, Kinetic Seas Incorporated (the “Company”) entered into a Securities Purchase Agreement with LABRYS FUND II, L.P. pursuant to which the Company issued an unsecured promissory note (the “Note”) in the principal amount of $148,500 for gross proceeds of $135,000.”
VWAV VisionWave Holdings, Inc.

VisionWave Holdings, Inc. incurred loan of $20,000,000 senior loan with YA II PN, Ltd. at 0% interest per annum (increasing to 18% upon an Event of Default) maturing 12 months from issuance.

“On February 26, 2026, VisionWave Holdings Inc. (the "Company") entered into a Letter Agreement (the "Letter Agreement") with YA II PN, Ltd. (the "Investor"), pursuant to which the Investor agreed to provide the Company with a $20,000,000 senior loan (the "Loan") on the terms and conditions set forth therein.”
RCL ROYAL CARIBBEAN CRUISES LTD

ROYAL CARIBBEAN CRUISES LTD incurred senior notes of $1,250,000,000 aggregate principal amount with The Bank of New York Mellon Trust Company, N.A. at 5.250% per annum maturing February 27, 2038.

“On February 27, 2026, Royal Caribbean Cruises Ltd. (the “Company”) completed its previously announced offering of $1,250,000,000 aggregate principal amount of 4.750% Senior Notes due 2033 (the “2033 Notes”) and $1,250,000,000 aggregate principal amount of the Company’s 5.250% Senior Notes due 2038 (the “2038 Notes” and, together with the 2033 Notes, the “Notes”)”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.